Engineering customized nanovaccines for enhanced cancer immunotherapy
Nanovaccines have gathered significant attention for their potential to elicit tumor-specific immunological responses. Despite notable progress in tumor immunotherapy, nanovaccines still encounter considerable challenges such as low delivery efficiency, limited targeting ability, and suboptimal effi...
Guardado en:
| Autores principales: | , , , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
KeAi Communications Co., Ltd.
2024-06-01
|
| Colección: | Bioactive Materials |
| Materias: | |
| Acceso en línea: | http://www.sciencedirect.com/science/article/pii/S2452199X24000732 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
